San Carlos, CA, United States of America

Venita DeAlmeida

This inventor holds 3 USPTO granted patents. Top assignee: Genentech, Inc.. Active years: 2011-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Venita DeAlmeida. Retrieved from https://idiyas.com/inventor/venita-dealmeida

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 66.7

Average Co-Inventor Count = 7.3

ph-index = 2

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2011-2017

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Venita DeAlmeida: Innovator in Antibody Research

Introduction

Venita DeAlmeida is a prominent inventor based in San Carlos, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 3 patents, her work has advanced the understanding and application of therapeutic antibodies.

Latest Patents

One of her notable inventions includes anti-LRP6 antibodies. This invention provides anti-LRP6 antibodies and methods of using them. A particular aspect of this invention features bispecific anti-LRP6 antibodies that inhibit signaling by multiple Wnt isoforms. This innovative approach has the potential to impact various therapeutic applications.

Career Highlights

Venita DeAlmeida is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. Her work at Genentech has allowed her to collaborate with some of the brightest minds in the industry, further enhancing her contributions to antibody research.

Collaborations

Some of her notable coworkers include James A Ernst and Paul Polakis. Their collaboration has fostered an environment of innovation and discovery, leading to advancements in the field.

Conclusion

Venita DeAlmeida's work in antibody research exemplifies the impact of innovation in biotechnology. Her contributions continue to shape the future of therapeutic applications, making her a key figure in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…